{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:42:04Z","timestamp":1761100924298,"version":"3.33.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.beha.2006.09.005","type":"journal-article","created":{"date-parts":[[2007,4,20]],"date-time":"2007-04-20T16:07:35Z","timestamp":1177085255000},"page":"247-263","source":"Crossref","is-referenced-by-count":23,"title":["Cardiac assessment of patients for haematopoietic stem cell transplantation"],"prefix":"10.1016","volume":"20","author":[{"given":"J.G.","family":"Coghlan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.E.","family":"Handler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.D.","family":"Kottaridis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3\u20134","key":"10.1016\/j.beha.2006.09.005_bib1","first-page":"50","article-title":"Swiss Transplant Working Group Blood and Marrow Transplantation Board. Haematopoietic stem cell transplantation in Switzerland. Report from the Swiss Transplant Working Group Blood and Marrow Transplantation (STABMT) Registry 1997\u20132003","volume":"136","author":"Passweg","year":"2006","journal-title":"Swiss Medical Weekly"},{"issue":"7\u20138","key":"10.1016\/j.beha.2006.09.005_bib2","first-page":"629","article-title":"Radionuclide ejection fraction in doxorubicin cardiotoxicity","volume":"65","author":"Morgan","year":"1981","journal-title":"Cancer Treatment Reports"},{"issue":"7","key":"10.1016\/j.beha.2006.09.005_bib3","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/(SICI)1097-0142(19971001)80:7<1317::AID-CNCR18>3.0.CO;2-A","article-title":"Cancer chemotherapy in the older patient: what the medical oncologist needs to know","volume":"80","author":"Balducci","year":"1997","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.beha.2006.09.005_bib4","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/sj.bmt.1705377","article-title":"EBMT activity survey 2004 and changes in disease indication over the past 15 years","volume":"37","author":"Gratwohl","year":"2006","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.beha.2006.09.005_bib5","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood-2005-06-2462","volume":"107","author":"Schonland","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.beha.2006.09.005_bib6","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/art.21908","article-title":"Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis","volume":"54","author":"Nash","year":"2006","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.beha.2006.09.005_bib7","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1196\/annals.1345.024","article-title":"Bone marrow transplantation in adults with thalassemia: treatment and long-term follow-up","volume":"1054","author":"Gaziev","year":"2005","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.beha.2006.09.005_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0268-960X(03)00006-7","article-title":"Hematopoietic stem cell transplantation in sickle cell disease","volume":"17","author":"Vermylen","year":"2003","journal-title":"Blood Reviews"},{"key":"10.1016\/j.beha.2006.09.005_bib9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10545-005-0258-8","article-title":"Trends in haematopoietic cell transplantation for inborn errors of metabolism","volume":"29","author":"Boelens","year":"2006","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1016\/j.beha.2006.09.005_bib10","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/sj.bmt.1705371","article-title":"Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma","volume":"37","author":"Buadi","year":"2006","journal-title":"Bone Marrow Transplantation"},{"issue":"7","key":"10.1016\/j.beha.2006.09.005_bib11","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1053\/euhj.1998.1057","article-title":"How to diagnose diastolic heart failure. European Study Group on Diastolic Heart Failure","volume":"19","author":"Working Group Report","year":"1998","journal-title":"European Heart Journal"},{"key":"10.1016\/j.beha.2006.09.005_bib12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.bmt.1703133","article-title":"Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977\u20131997","volume":"28","author":"Murdych","year":"2001","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.beha.2006.09.005_bib13","first-page":"173","article-title":"Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicity","volume":"5","author":"Bearman","year":"1990","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.beha.2006.09.005_bib14","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1002\/1097-0142(19860515)57:10<2061::AID-CNCR2820571031>3.0.CO;2-H","article-title":"Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive transplantations","volume":"57","author":"Cazin","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2006.09.005_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/sj.bmt.1704540","article-title":"Low transplant-related mortality with allogeneic stem cell transplantation in elderly patients","volume":"34","author":"Shapira","year":"2004","journal-title":"Bone Marrow Transplantation"},{"issue":"12","key":"10.1016\/j.beha.2006.09.005_bib16","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1038\/sj.leu.2403967","volume":"19","author":"Aoudjhane","year":"2005","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.beha.2006.09.005_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF00442410","article-title":"Cyclophosphamide cardiotoxicity","volume":"134","author":"von Bernuth","year":"1980","journal-title":"European Journal of Pediatrics"},{"issue":"6","key":"10.1016\/j.beha.2006.09.005_bib18","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/cncr.2820360904","article-title":"High dose cyclophosphamide therapy in solid tumors. Therapeutic, toxic, and immunosuppressive effects","volume":"36","author":"Mullins","year":"1975","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.beha.2006.09.005_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0046-8177(76)80004-4","article-title":"Cardiac pathologic findings in patients treated with bone marrow transplantation","volume":"7","author":"Buja","year":"1976","journal-title":"Human Pathology"},{"issue":"1","key":"10.1016\/j.beha.2006.09.005_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/bjc.1984.7","article-title":"Prevention of acute deaths in mice after very high dose cyclophosphamide by divided dose schedule","volume":"49","author":"Evans","year":"1984","journal-title":"British Journal of Cancer"},{"issue":"8","key":"10.1016\/j.beha.2006.09.005_bib21","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/1097-0142(19840415)53:8<1660::AID-CNCR2820530807>3.0.CO;2-0","article-title":"Acute anthracycline cardiotoxicity. Comparative morphologic study of three analogues","volume":"53","author":"Taylor","year":"1984","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.beha.2006.09.005_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00000421-198904000-00007","article-title":"Ten-year results of FAC adjuvant chemotherapy trial in breast cancer","volume":"12","author":"Buzdar","year":"1989","journal-title":"American Journal of Clinical Oncology"},{"issue":"34","key":"10.1016\/j.beha.2006.09.005_bib23","doi-asserted-by":"crossref","first-page":"8597","DOI":"10.1200\/JCO.2005.02.5841","article-title":"Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study","volume":"23","author":"Doyle","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"11","key":"10.1016\/j.beha.2006.09.005_bib24","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1002\/cncr.21478","article-title":"Notable effects of angiotensin II receptor blocker, valsartan, on acute cardiotoxic changes after standard chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone","volume":"104","author":"Nakamae","year":"2005","journal-title":"Cancer"},{"issue":"1\u20132","key":"10.1016\/j.beha.2006.09.005_bib25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11010-006-1169-1","article-title":"Lupeol and its ester ameliorate the cyclophosphamide provoked cardiac lysosomal damage studied in rat","volume":"282","author":"Sudharsan","year":"2006","journal-title":"Molecular and Cellular Biochemistry"},{"key":"10.1016\/j.beha.2006.09.005_bib26","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1182\/blood-2004-01-0390","article-title":"Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation","volume":"104","author":"Dispenzieri","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.beha.2006.09.005_bib27","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/bja\/76.6.790","article-title":"Sepsis-induced vasoparalysis does not involve the cerebral vasculature; indirect evidence from autoregulation and carbon dioxide reactivity studies","volume":"76","author":"Matta","year":"1996","journal-title":"British Journal of Anaesthesia"},{"key":"10.1016\/j.beha.2006.09.005_bib28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00003246-198904000-00005","article-title":"Left ventricular function during sepsis","volume":"17","author":"Artucio","year":"1989","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.beha.2006.09.005_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1113\/expphysiol.1989.sp003273","article-title":"Studies on the circulation in normotensive febrile patients","volume":"74","author":"Weinberg","year":"1989","journal-title":"Quarterly Journal of Experimental Physiology"},{"key":"10.1016\/j.beha.2006.09.005_bib30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.1365-2044.2001.01866.x","article-title":"The haemodynamics of human septic shock","volume":"56","author":"Mackenzie","year":"2001","journal-title":"Anaesthesia"},{"key":"10.1016\/j.beha.2006.09.005_bib31","series-title":"Heart Failure: Cardiac Function and Dysfunction","first-page":"7.1","article-title":"Assessment of heart failure","volume":"4","author":"Young","year":"1995"},{"issue":"4","key":"10.1016\/j.beha.2006.09.005_bib32","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jacc.2005.11.021","article-title":"Health status identifies heart failure outpatients at risk for hospitalization or death","volume":"47","author":"Heidenreich","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"issue":"16","key":"10.1016\/j.beha.2006.09.005_bib33","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1161\/CIRCULATIONAHA.105.587519","article-title":"Myocardial structure and function differ in systolic and diastolic heart failure","volume":"113","author":"van Heerebeek","year":"2006","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.beha.2006.09.005_bib34","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.amjcard.2005.11.059","article-title":"Factors associated with decreased cerebral blood flow in congestive heart failure secondary to idiopathic dilated cardiomyopathy","volume":"97","author":"Choi","year":"2006","journal-title":"The American Journal of Cardiology"},{"key":"10.1016\/j.beha.2006.09.005_bib35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cardfail.2004.10.006","article-title":"Left heart failure with a normal ejection fraction: identification of different pathophysiologic mechanisms","volume":"11","author":"Maurer","year":"2005","journal-title":"Journal of Cardiac Failure"},{"issue":"5","key":"10.1016\/j.beha.2006.09.005_bib36","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1136\/hrt.2005.063768","article-title":"Echocardiographic features and brain natriuretic peptides in patients presenting with heart failure and preserved systolic function","volume":"92","author":"Thomas","year":"2006","journal-title":"Heart"},{"issue":"supplement 2","key":"10.1016\/j.beha.2006.09.005_bib37","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1007\/s00277-003-0771-5","volume":"82","author":"Bertz","year":"2003","journal-title":"Annals of Hematology"},{"issue":"4","key":"10.1016\/j.beha.2006.09.005_bib38","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/hrt.2003.022277","article-title":"5-flurouracil induced coronary artery vasospasm","volume":"90","author":"Suresh","year":"2004","journal-title":"Heart"},{"issue":"10","key":"10.1016\/j.beha.2006.09.005_bib39","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.biopha.2004.12.003","article-title":"Effect of epirubicin-based chemotherapy and dexrazoxane supplementation on QT dispersion in non-Hodgkin lymphoma patients","volume":"59","author":"Galetta","year":"2005","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"24","key":"10.1016\/j.beha.2006.09.005_bib40","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1161\/CIRCULATIONAHA.105.561423","article-title":"Candesartan in Heart Failure Reduction in Mortality (CHARM) Investigators. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients","volume":"112","author":"Solomon","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.beha.2006.09.005_bib41","first-page":"271","article-title":"Extension of QT interval as a consequence of risk factor accumulation \u2013 case study","volume":"52","author":"Sisakova","year":"2006","journal-title":"Vnitrni Lekarstvi"},{"issue":"7","key":"10.1016\/j.beha.2006.09.005_bib42","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1161\/hc0702.105124","article-title":"Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel","volume":"105","author":"Moss","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.beha.2006.09.005_bib43","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1542-474X.2005.00055.x","article-title":"Noninvasive risk stratification of subjects with a Brugada-type electrocardiogram and no history of cardiac arrest","volume":"10","author":"Ikeda","year":"2005","journal-title":"Annals of Noninvasive Electrocardiology"},{"issue":"14","key":"10.1016\/j.beha.2006.09.005_bib44","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1161\/01.CIR.0000143375.93288.82","article-title":"Natural history and risk stratification of arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"110","author":"Hulot","year":"2004","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.beha.2006.09.005_bib45","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.ahj.2005.01.005","article-title":"The Italian registry for hypertrophic cardiomyopathy: a nationwide survey","volume":"150","author":"Cecchi","year":"2005","journal-title":"American Heart Journal"},{"issue":"9A","key":"10.1016\/j.beha.2006.09.005_bib46","doi-asserted-by":"crossref","first-page":"83R","DOI":"10.1016\/S0002-9149(99)00707-9","article-title":"Lessons from antiarrhythmic trials involving class III antiarrhythmic drugs","volume":"84","author":"Yap","year":"1999","journal-title":"The\u00a0American Journal of Cardiology"},{"issue":"3","key":"10.1016\/j.beha.2006.09.005_bib47","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1520\/JFS13446J","article-title":"Isolated myocardial fibrosis as a cause of sudden cardiac death and its possible relation to myocarditis","volume":"38","author":"Lecomte","year":"1993","journal-title":"Journal of Forensic Sciences"},{"issue":"3","key":"10.1016\/j.beha.2006.09.005_bib48","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"The New England Journal of Medicine"},{"issue":"8","key":"10.1016\/j.beha.2006.09.005_bib49","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jacc.2003.08.013","volume":"42","author":"Blomstrom-Lundqvist","year":"2003","journal-title":"Journal of the American College of Cardiology"},{"issue":"5","key":"10.1016\/j.beha.2006.09.005_bib50","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/annonc\/mdf132","article-title":"Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients","volume":"13","author":"Jensen","year":"2002","journal-title":"Annals of Oncology"},{"issue":"4","key":"10.1016\/j.beha.2006.09.005_bib51","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/pbc.20281","article-title":"Late cardiac evaluation of children with solid tumors after anthracycline chemotherapy","volume":"44","author":"Pinarli","year":"2005","journal-title":"Pediatric Blood & Cancer"},{"issue":"3","key":"10.1016\/j.beha.2006.09.005_bib52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1388-9842(01)00201-X","article-title":"Chemotherapy-induced cardiotoxicity: current practice and prospects of\u00a0prophylaxis","volume":"4","author":"Gharib","year":"2002","journal-title":"European Journal of Heart Failure"},{"issue":"3","key":"10.1016\/j.beha.2006.09.005_bib53","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.coc.0000145984.39639.0d","article-title":"IIVP salvage regimen induces high response rates in patients with relapsed lymphoma before autologous stem cell transplantation","volume":"28","author":"Abali","year":"2005","journal-title":"American Journal of Clinical Oncology"},{"issue":"2","key":"10.1016\/j.beha.2006.09.005_bib54","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.critrevonc.2004.09.010","article-title":"Treatment of older patients with AML","volume":"56","author":"Buchner","year":"2005","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"1","key":"10.1016\/j.beha.2006.09.005_bib55","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.20747","article-title":"Suppression of mitoxantrone cardiotoxicity in multiple sclerosis patients by dexrazoxane","volume":"59","author":"Bernitsas","year":"2006","journal-title":"Annals of Neurology"},{"issue":"2","key":"10.1016\/j.beha.2006.09.005_bib56","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2169\/internalmedicine.44.89","article-title":"Clinical significance of cyclophosphamide-induced cardiotoxicity","volume":"44","author":"Taniguchi","year":"2005","journal-title":"Internal Medicine"},{"issue":"5","key":"10.1016\/j.beha.2006.09.005_bib57","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/annonc\/mdf231","article-title":"Detection of anthracycline-induced cardiotoxicity: is there light at the end of the tunnel?","volume":"13","author":"Suter","year":"2002","journal-title":"Annals of Oncology"},{"issue":"5","key":"10.1016\/j.beha.2006.09.005_bib58","first-page":"430","article-title":"The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia","volume":"52","author":"Horacek","year":"2005","journal-title":"Neoplasma"},{"issue":"8","key":"10.1016\/j.beha.2006.09.005_bib59","first-page":"1197","article-title":"Plasma concentrations of NT-pro-BNP and cardiac troponin-I in relation to doxorubicin-induced cardiomyopathy and cardiac function in childhood malignancy","volume":"26","author":"Soker","year":"2005","journal-title":"Saudi Medical Journal"},{"issue":"10","key":"10.1016\/j.beha.2006.09.005_bib60","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.bmt.1704656","article-title":"Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis","volume":"34","author":"Saccardi","year":"2004","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.beha.2006.09.005_bib61","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/ard.62.11.1088","article-title":"Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach","volume":"62","author":"Mukerjee","year":"2003","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"5","key":"10.1016\/j.beha.2006.09.005_bib62","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.revmed.2004.01.019","article-title":"Pulmonary arterial hypertension in systemic sclerosis: definition of a screening algorithm for early detection (ItinerAIR-Sclerodermie Study)","volume":"25","author":"Hachulla","year":"2004","journal-title":"La Revue de Medecine Interne"},{"key":"10.1016\/j.beha.2006.09.005_bib63","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/art.11073","article-title":"Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population","volume":"48","author":"Mayes","year":"2003","journal-title":"Arthritis and Rheumatism"},{"issue":"6","key":"10.1016\/j.beha.2006.09.005_bib64","article-title":"Pulmonary hypertension in patients with connective tissue diseases","volume":"59","author":"Yoshida","year":"2001","journal-title":"Nippon Rinsho"},{"key":"10.1016\/j.beha.2006.09.005_bib65","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/0002-8703(95)90278-3","article-title":"Five year follow up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus","volume":"129","author":"Winslow","year":"1995","journal-title":"American Heart Journal"},{"issue":"10","key":"10.1016\/j.beha.2006.09.005_bib66","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1191\/0961203305lu2228oa","article-title":"Acute lupus myocarditis: clinical features and outcome of an oriental case series","volume":"14","author":"Law","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.beha.2006.09.005_bib67","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1183\/09031936.98.12051124","article-title":"Pulmonary function in sickle cell disease with or without acute chest syndrome","volume":"12","author":"Santoli","year":"1998","journal-title":"The European Respiratory Journal"},{"issue":"9","key":"10.1016\/j.beha.2006.09.005_bib68","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.amjmed.2004.03.034","article-title":"Pulmonary hypertension in sickle cell disease","volume":"117","author":"Ataga","year":"2004","journal-title":"The American Journal of Medicine"},{"issue":"9","key":"10.1016\/j.beha.2006.09.005_bib69","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa035477","article-title":"Pulmonary hypertension as a risk factor for death in patients with sickle cell disease","volume":"350","author":"Gladwin","year":"2004","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.beha.2006.09.005_bib70","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1182\/blood-2002-03-0948","article-title":"Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival","volume":"101","author":"Castro","year":"2003","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.beha.2006.09.005_bib71","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/archinte.148.7.1526","article-title":"Sickle cell heart disease. Two-dimensional echo and Doppler ultrasonographic findings in the hearts of adult patients with sickle cell anemia","volume":"148","author":"Simmons","year":"1988","journal-title":"Archives of Internal Medicine"},{"issue":"1\u20132","key":"10.1016\/j.beha.2006.09.005_bib72","first-page":"151","article-title":"Ultrastructural alterations in the myocardium of patients with sickle cell anemia","volume":"33","author":"Tap","year":"2001","journal-title":"Journal of Submicroscopic Cytology and Pathology"},{"key":"10.1016\/j.beha.2006.09.005_bib73","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/01.CIR.30.5.698","article-title":"Late cardiac complications of chronic, refractory anemia with hemochromatosis","volume":"30","author":"Engle","year":"1964","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.beha.2006.09.005_bib74","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1378\/chest.127.5.1523","article-title":"Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia","volume":"127","author":"Aessopos","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.beha.2006.09.005_bib75","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199409013310903","article-title":"Survival in medically treated patients with homozygous \u03b2-thalassemia","volume":"331","author":"Olivieri","year":"1994","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.beha.2006.09.005_bib76","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1182\/blood-2003-09-3167","article-title":"Thalassemia clinical research network. complications of beta-thalassemia major in North America","volume":"104","author":"Cunningham","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.beha.2006.09.005_bib77","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0002-8703(97)70091-7","article-title":"Pulmonary hypertension in patients with thalassemia major","volume":"134","author":"Du","year":"1997","journal-title":"American Heart Journal"},{"issue":"2","key":"10.1016\/j.beha.2006.09.005_bib78","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/jcp.2004.017293","article-title":"Amyloid in the cardiovascular system: a review","volume":"58","author":"Kholova","year":"2005","journal-title":"Journal of Clinical Pathology"},{"issue":"7","key":"10.1016\/j.beha.2006.09.005_bib79","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/sj.bmt.1705112","article-title":"Autologous transplantation for primary systemic AL amyloidosis is feasible outside a major amyloidosis referral centre: the Calgary BMT Program experience","volume":"36","author":"Chow","year":"2005","journal-title":"Bone Marrow Transplantation"},{"issue":"1","key":"10.1016\/j.beha.2006.09.005_bib80","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/sj.bmt.1705395","article-title":"Multiple myeloma-associated AL amyloidosis: is a distinctive therapeutic approach warranted?","volume":"38","author":"Bahlis","year":"2006","journal-title":"Bone Marrow Transplantation"},{"issue":"4","key":"10.1016\/j.beha.2006.09.005_bib81","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1046\/j.1365-2141.1998.00772.x","article-title":"Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients","volume":"101","author":"Moreau","year":"1998","journal-title":"British Journal of Haematology"},{"issue":"7","key":"10.1016\/j.beha.2006.09.005_bib82","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.bmt.1703200","article-title":"An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis","volume":"28","author":"Sanchorawala","year":"2001","journal-title":"Bone Marrow Transplantation"},{"issue":"18","key":"10.1016\/j.beha.2006.09.005_bib83","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1200\/JCO.2004.03.029","article-title":"Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis","volume":"22","author":"Dispenzieri","year":"2004","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1016\/j.beha.2006.09.005_bib84","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/adc.73.3.259","article-title":"Cardiac involvement in mucopolysaccharidoses: effects of allogeneic bone marrow transplantation","volume":"73","author":"Gatzoulis","year":"1995","journal-title":"Archives of Disease in Childhood"},{"key":"10.1016\/j.beha.2006.09.005_bib85","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/sj.bmt.1702744","article-title":"Acute heart failure after allogeneic blood stem cell transplantation due to massive myocardial infiltration by cytotoxic T cells of donor origin","volume":"27","author":"Platzbecker","year":"2001","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.beha.2006.09.005_bib86","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/sj.bmt.1704625","article-title":"Coronary vessel involvement by chronic graft-versus-host disease presenting as sudden cardiac death","volume":"34","author":"Prevost","year":"2004","journal-title":"Bone Marrow Transplantation"},{"issue":"5","key":"10.1016\/j.beha.2006.09.005_bib87","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/pbc.20621","article-title":"Acute graft-versus-host disease of the heart","volume":"47","author":"Roberts","year":"2006","journal-title":"Pediatric Blood & Cancer"},{"key":"10.1016\/j.beha.2006.09.005_bib88","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bbmt.2005.07.002","article-title":"Cardiac manifestations of graft-versus-host disease","volume":"11","author":"Rackley","year":"2005","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.beha.2006.09.005_bib89","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/sj.bmt.1703952","article-title":"Should we be performing more combined hematopoietic stem cell plus solid organ transplants?","volume":"31","author":"Chiang","year":"2003","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.beha.2006.09.005_bib90","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1399-0012.1994.tb00937.x","article-title":"Orthotopic cardiac transplantation for dilated cardiomyopathy after allogeneic bone marrow transplantation","volume":"8","author":"Ramrakha","year":"1994","journal-title":"Clinical Transplantation"},{"key":"10.1016\/j.beha.2006.09.005_bib91","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1182\/blood.V96.7.2419","article-title":"In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation","volume":"96","author":"Kottaridis","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.beha.2006.09.005_bib92","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood.V99.3.1071","article-title":"Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen","volume":"99","author":"Chakraverty","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2006.09.005_bib93","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bmt.1703098","article-title":"Acute left ventricular failure following melphalan and fludarabine conditioning","volume":"28","author":"Ritchie","year":"2001","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.beha.2006.09.005_bib94","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/sj.bmt.1705145","article-title":"Cardiac complications after haploidentical HLA-mismatched hematopoietic stem cell transplantation using in vivo alemtuzumab","volume":"36","author":"Oshima","year":"2005","journal-title":"Bone Marrow Transplantation"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169260600065X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169260600065X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T21:23:00Z","timestamp":1736976180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169260600065X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":94,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S152169260600065X"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2006.09.005","relation":{},"ISSN":["1521-6926"],"issn-type":[{"type":"print","value":"1521-6926"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}